Corneal changes after fulguration and cross-linking in experiment
- Authors: Boutaba R.1, Trufanov S.V.1, Riks I.A.1, Ezugbaya M.2, Yukina G.Y.1, Sukhorukova E.G.1, Papanyan S.S.2, Nikolaenko S.L.1, Gorchakova O.V.1
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- Diagnostic Center No. 7 (ocular)
- Issue: Vol 16, No 4 (2023)
- Pages: 67-77
- Section: Experimental trials
- URL: https://journals.rcsi.science/ov/article/view/254574
- DOI: https://doi.org/10.17816/OV568953
- ID: 254574
Cite item
Abstract
BACKGROUND: Severe progressive forms of infectious keratitis are often associated with the risk of violation of the structural integrity of the eyeball and the development of endophthalmitis. In the presence of negative dynamics against the background of conservative etiotropic therapy for severe keratitis, it is advisable to use surgical methods of treatment. The combination of two surgical methods of influencing a pharmacoresistant infectious process in the cornea — cross-linking and fulguration — is promising and requires further investigation.
AIM: In the experiment, to evaluate the effect on the corneal tissue of various modes of direct current fulguration, as well as in combination with cross-linking as well.
MATERIALS AND METHODS: An in vivo experimental study was carried out on 19 rabbits (38 eyes) of the Soviet Chinchilla breed, the average body weight of the animals was 2.5–4.0 kg. Depending on the stage of the study, the type and power of exposure during fulguration, the rabbits were divided into 3 groups.
RESULTS: When the cornea was exposed to fulguration in mode 5, the changes covered only 10–15 % of the anterior stroma, about 50 μm, and both clinically and histologically were not sufficient. When exposed to mode 6 and 7 after 3 months, changes in the stromal structure extended by about 150 µm. When using mode 8, there was a slight proliferation of connective tissue between the Descemet’s membrane and the endothelium. The combination of cross-linking with fulguration made it possible to obtain a more compact structure of the anterior layers of the corneal stroma and stability of the epithelium.
CONCLUSIONS: Fulguration may be a relatively safe treatment for the cornea in pharmacoresistant progressive keratitis. Fulguration and corneal cross-linking can potentiate each other’s effect. Fulguration mode 7 (1.5 W) is optimal at corneal exposition for the eradication of infectious agents.
Full Text
##article.viewOnOriginalSite##About the authors
Rafik Boutaba
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: dr.rafik_boutaba@mail.ru
ORCID iD: 0000-0002-3700-8255
SPIN-code: 3416-3915
Russian Federation, 6–8 L’va Tolstogo st, Saint-Petersburg, 197022
Sergey V. Trufanov
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: trufanov05@mail.ru
ORCID iD: 0000-0003-4360-793X
SPIN-code: 1603-8931
MD, Dr. Sci. (Medicine)
Russian Federation, Saint PetersburgInna A. Riks
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: riks0503@yandex.ru
ORCID iD: 0000-0002-5187-1047
SPIN-code: 4297-6543
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgMaggie Ezugbaya
Diagnostic Center No. 7 (ocular)
Email: maggie-92@mail.ru
ORCID iD: 0000-0002-0421-1804
Russian Federation, Saint Petersburg
Galina Yu. Yukina
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: pipson@inbox.ru
ORCID iD: 0000-0001-8888-4135
SPIN-code: 2533-2084
Cand. Sci. (Biology), Assistant Professor
Russian Federation, Saint PetersburgElena G. Sukhorukova
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: len48@inbox.ru
ORCID iD: 0000-0001-5521-7248
SPIN-code: 2115-9041
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgSanasar S. Papanyan
Diagnostic Center No. 7 (ocular)
Email: Dr.papanyan@yandex.ru
ORCID iD: 0000-0003-3766-2211
SPIN-code: 9794-4692
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgSvetlana L. Nikolaenko
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: nikolaenkos@yandex.ru
ORCID iD: 0000-0002-5184-3775
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgOlga V. Gorchakova
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: gorchakova-spmu@yandex.ru
ORCID iD: 0000-0001-5458-4329
MD, Cand. Sci. (Medicine)
Russian Federation, Saint PetersburgReferences
- Raj A, Bahadur H, Dhasmana R. Outcome of therapeutic penetrating keratoplasty in advanced infectious keratitis. J Curr Ophthalmol. 2018;30(4):315–332. doi: 10.1016/j.joco.2018.04.0017
- Tuli S, Gray M. Surgical management of corneal infections. Curr Opin Ophthalmol. 2016;27(4):340–347. doi: 10.1097/ICU.0000000000000274
- Trufanov SV, Shakhbazyan NP, Zaitsev AV, Rozinova VN. Surgical management of infectious keratitis. The Russian Annals of Ophthalmology. 2021;137(4):128135. (In Russ.) doi: 10.17116/oftalma2021137041128
- Trufanov SV, Zaitsev AV, Shakhbazyan NP. Crosslinking and fulguration in the treatment of Acanthamoebic keratitis. Ophthalmology in Russia. 2020;17(4):725–732. (In Russ.) doi: 10.18008/1816-5095-2020-4-725-732
- Tsugita A, Okada Y, Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103(2):360–363. doi: 10.1016/0005-2787(65)90182-6
- Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci. 2006;35(1):5–17. doi: 10.1016/j.transci.2006.01.007
- Marschner S, Goodrich R. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother. 2011;38(1):8–18. doi: 10.1159/000324160
- Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 2004;44(6):877–885. doi: 10.1111/j.1537-2995.2004.03355
- Reddy HL, Dayan AD, Cavagnaro J, et al. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev. 2008;22(2):133–153. doi: 10.1016/j.tmrv.2007.12.003
- Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light а therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis. Ophthalmology. 2011;118(2): 324–331. doi: 10.1016/j.ophtha.2010.06.041
- Garduño-Vieyra L, Gonzalez-Sanchez CR, Hernandez-Da Mota SE. Ultraviolet — a light and riboflavin therapy for Acanthamoeba keratitis. Case Rep Ophthalmol. 2011;2(2):291–295. doi: 10.1159/000331707
- Berra M, Galperin G, Boscaro G, et al. Treatment of Acanthamoeba keratitis by corneal cross-linking. Cornea. 2013;32(2):174–178. doi: 10.1097/ICO.0b013e31825cea99
- Del Buey MA, Cristobal JA, Casas P, et al. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet A for Acanthamoeba isolates. Am J Ophthalmol. 2012;153(3):399–404. doi: 10.1016/j.ajo.2011.07.025
- Lamy R, Chan E, Good SD, et al. Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clin Exp Ophthalmol. 2016;44(3):181–187. doi: 10.1111/ceo.12644
- Kashiwabuchi RT, Carvalho FRS, Khan YA, et al. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Investig Ophthalmol Vis Sci. 2011;52(13):9333–9338. doi: 10.1167/iovs.11-8382
- Price MO, Price FW Jr. Corneal cross-linking in the treatment of corneal ulcers. Curr Opin Ophthalmol. 2016;27(3):250–255. doi: 10.1097/ICU.0000000000000248
- Kasparova EA, Zajcev AV, Kasparova EA, Kasparov AA. Micro diathermocoagulation in the treatment of infectious corneal ulcers. Ophthalmology in Russia. 2016;13(3):157–162. (In Russ.) doi: 10.18008/1816-5095-2016-3-157-162
- Patent RU No. 2732696/ 2020 Sept 21. Nespor Radek (CZ). A portable device used primarily for cauterization and drying by spark for cauterization and drying by means of a spark discharge. Moscow: FIPS. (In Russ.)
Supplementary files
![](/img/style/loading.gif)